Early Detection of Pancreatic Cancer: Opportunities and Challenges

Aatur D. Singhi, Eugene J. Koay, Suresh T Chari, Anirban Maitra

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Most patients with pancreatic ductal adenocarcinoma (PDAC) present with symptomatic, surgically unresectable disease. Although the goal of early detection of PDAC is laudable and likely to result in significant improvement in overall survival, the relatively low prevalence of PDAC renders general population screening infeasible. The challenges of early detection include identification of at-risk individuals in the general population who would benefit from longitudinal surveillance programs and appropriate biomarker and imaging-based modalities used for PDAC surveillance in such cohorts. In recent years, various subgroups at higher-than-average risk for PDAC have been identified, including those with familial risk due to germline mutations, a history of pancreatitis, patients with mucinous pancreatic cysts, and elderly patients with new-onset diabetes. The last 2 categories are discussed at length in terms of the opportunities and challenges they present for PDAC early detection. We also discuss current and emerging imaging modalities that are critical to identifying early, potentially curable PDAC in high-risk cohorts on surveillance.

Original languageEnglish (US)
Pages (from-to)2024-2040
Number of pages17
JournalGastroenterology
Volume156
Issue number7
DOIs
StatePublished - May 1 2019

Fingerprint

Pancreatic Neoplasms
Early Detection of Cancer
Adenocarcinoma
Pancreatic Cyst
Germ-Line Mutation
Pancreatitis
Population
Biomarkers
Survival

Keywords

  • Biomarker
  • Pre-diagnostic
  • Risk Stratification

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Early Detection of Pancreatic Cancer : Opportunities and Challenges. / Singhi, Aatur D.; Koay, Eugene J.; Chari, Suresh T; Maitra, Anirban.

In: Gastroenterology, Vol. 156, No. 7, 01.05.2019, p. 2024-2040.

Research output: Contribution to journalArticle

Singhi, Aatur D. ; Koay, Eugene J. ; Chari, Suresh T ; Maitra, Anirban. / Early Detection of Pancreatic Cancer : Opportunities and Challenges. In: Gastroenterology. 2019 ; Vol. 156, No. 7. pp. 2024-2040.
@article{e4d72d757f43472589cf1c8db476f8b9,
title = "Early Detection of Pancreatic Cancer: Opportunities and Challenges",
abstract = "Most patients with pancreatic ductal adenocarcinoma (PDAC) present with symptomatic, surgically unresectable disease. Although the goal of early detection of PDAC is laudable and likely to result in significant improvement in overall survival, the relatively low prevalence of PDAC renders general population screening infeasible. The challenges of early detection include identification of at-risk individuals in the general population who would benefit from longitudinal surveillance programs and appropriate biomarker and imaging-based modalities used for PDAC surveillance in such cohorts. In recent years, various subgroups at higher-than-average risk for PDAC have been identified, including those with familial risk due to germline mutations, a history of pancreatitis, patients with mucinous pancreatic cysts, and elderly patients with new-onset diabetes. The last 2 categories are discussed at length in terms of the opportunities and challenges they present for PDAC early detection. We also discuss current and emerging imaging modalities that are critical to identifying early, potentially curable PDAC in high-risk cohorts on surveillance.",
keywords = "Biomarker, Pre-diagnostic, Risk Stratification",
author = "Singhi, {Aatur D.} and Koay, {Eugene J.} and Chari, {Suresh T} and Anirban Maitra",
year = "2019",
month = "5",
day = "1",
doi = "10.1053/j.gastro.2019.01.259",
language = "English (US)",
volume = "156",
pages = "2024--2040",
journal = "Gastroenterology",
issn = "0016-5085",
publisher = "W.B. Saunders Ltd",
number = "7",

}

TY - JOUR

T1 - Early Detection of Pancreatic Cancer

T2 - Opportunities and Challenges

AU - Singhi, Aatur D.

AU - Koay, Eugene J.

AU - Chari, Suresh T

AU - Maitra, Anirban

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Most patients with pancreatic ductal adenocarcinoma (PDAC) present with symptomatic, surgically unresectable disease. Although the goal of early detection of PDAC is laudable and likely to result in significant improvement in overall survival, the relatively low prevalence of PDAC renders general population screening infeasible. The challenges of early detection include identification of at-risk individuals in the general population who would benefit from longitudinal surveillance programs and appropriate biomarker and imaging-based modalities used for PDAC surveillance in such cohorts. In recent years, various subgroups at higher-than-average risk for PDAC have been identified, including those with familial risk due to germline mutations, a history of pancreatitis, patients with mucinous pancreatic cysts, and elderly patients with new-onset diabetes. The last 2 categories are discussed at length in terms of the opportunities and challenges they present for PDAC early detection. We also discuss current and emerging imaging modalities that are critical to identifying early, potentially curable PDAC in high-risk cohorts on surveillance.

AB - Most patients with pancreatic ductal adenocarcinoma (PDAC) present with symptomatic, surgically unresectable disease. Although the goal of early detection of PDAC is laudable and likely to result in significant improvement in overall survival, the relatively low prevalence of PDAC renders general population screening infeasible. The challenges of early detection include identification of at-risk individuals in the general population who would benefit from longitudinal surveillance programs and appropriate biomarker and imaging-based modalities used for PDAC surveillance in such cohorts. In recent years, various subgroups at higher-than-average risk for PDAC have been identified, including those with familial risk due to germline mutations, a history of pancreatitis, patients with mucinous pancreatic cysts, and elderly patients with new-onset diabetes. The last 2 categories are discussed at length in terms of the opportunities and challenges they present for PDAC early detection. We also discuss current and emerging imaging modalities that are critical to identifying early, potentially curable PDAC in high-risk cohorts on surveillance.

KW - Biomarker

KW - Pre-diagnostic

KW - Risk Stratification

UR - http://www.scopus.com/inward/record.url?scp=85064560866&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064560866&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2019.01.259

DO - 10.1053/j.gastro.2019.01.259

M3 - Article

C2 - 30721664

AN - SCOPUS:85064560866

VL - 156

SP - 2024

EP - 2040

JO - Gastroenterology

JF - Gastroenterology

SN - 0016-5085

IS - 7

ER -